OKTA Form 4: COO Exercised Options and Sold 2,410 Shares
Rhea-AI Filing Summary
Eric R. Kelleher, President and Chief Operating Officer of Okta, Inc. (OKTA), reported multiple transactions dated 10/01/2025. He acquired 2,410 Class A shares through option exercise and a related conversion of Class B shares, showing a $8.97 option exercise price for one grant and a zero-dollar conversion for the Class B shares. On the same date, he sold a total of 2,410 Class A shares under a Rule 10b5-1 trading plan adopted April 15, 2025 — 1,610 shares at a weighted average price of $91.4495 and 800 shares at a weighted average price of $92.2925. After these transactions, the filing shows beneficial ownership of 9,174 Class A shares. The filing notes that certain options were fully vested and exercisable.
Positive
- Options fully vested for the reported grants, allowing orderly exercise and disposition
- Sales executed under a Rule 10b5-1 plan (adopted April 15, 2025), indicating pre-planned transactions
Negative
- Total disposition of 2,410 Class A shares on 10/01/2025, reducing holdings to 9,174 shares
- Sales at weighted average prices ~ $91.45 and $92.29 realize significant insider proceeds which reduce insider stake
Insights
TL;DR: Insider exercised low-strike options and sold the same number of shares under a 10b5-1 plan, ending with 9,174 shares.
The filing shows the Reporting Person exercised options with a $8.97 strike and converted Class B shares into Class A shares, acquiring 2,410 shares. Footnote disclosure confirms those options are fully vested and exercisable, which is an explicit alignment detail.
The same date records dispositions of 2,410 Class A shares in multiple transactions under a Rule 10b5-1 plan at weighted average prices of $91.4495 and $92.2925. Because the sales were made pursuant to a pre-established plan (adopted April 15, 2025), the filing documents an orderly disposition rather than ad hoc selling.
FAQ
What did Okta insider Eric Kelleher report on Form 4 (OKTA)?
How many shares did the insider sell and at what prices?
Were the optioned shares vested when exercised?
Was the selling done under an automatic trading plan?
What is the Reporting Person's beneficial ownership after the transactions?
What options and derivative holdings are disclosed?